Latest News
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Innventure, Inc. of Class Action Lawsuit and Upcoming Deadlines - INV
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Innventure, Inc. ("Innventure" or the "Company") (NASDAQ: INV).
Kaplan Fox Notifies Investors of Simply Good Foods Company (SMPL) of a Securities Fraud Class Action Deadline on October 13, 2026
New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against The Simply Good Foods Company ("Simply Good" or the
Kaplan Fox Notifies Investors of DICK's Sporting Goods, Inc. (DKS) of the Lead Plaintiff Deadline on November 3, 2026
New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DICK's Sporting Goods, Inc. ("Dick's Sporting Goods
AARD FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AARD
New York, New York--(Newsfile Corp. - September 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock p
LINC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Lincoln Educational Services Investors of Securities Class Action Lawsuit Deadline on November 10, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lincoln To Contact Him Directly To Discuss Their Options If you purchased or acquired
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in The Simply Good Foods Company of Class Action Lawsuit and Upcoming Deadlines - SMPL
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against The Simply Good Foods Company ("Simply Good Foods" or the "Company") (NASDAQ: SMPL).
Kaplan Fox Advises Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm Regarding a Securities Investigation
New York, New York--(Newsfile Corp. - September 24, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Cellebrite DI Ltd. ("Cellebrite" or the "Company") (NAS
Burcon Announces Shareholder Meeting Results and Updates Commercial Guidance
Customer demand remains strong as Company accelerates investment in manufacturing infrastructure and reliability Vancouver, British Columbia--(Newsfile Corp. - September 24, 2026) - Burcon NutraScienc
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Children's Place, Inc. - PLCE
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The Children's Place, Inc. ("The Children's Place" or the "Company") (NASDAQ: PLCE).
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadlines - ARDX
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. ("Ardelyx" or the "Company") (NASDAQ: ARDX).
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ: AVXL).
Robbins LLP is Investigating Allegations that Baidu, Inc. Misled Investors Regarding the Ability of its AI Business to Mitigate Rapid Declines in its Legacy Online Marketing Business
San Diego, California--(Newsfile Corp. - September 24, 2026) - Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased o
Pfizer: Poised For Gains With A New Drug Pipeline And Cost-Cutting Plans
Pfizer Inc. faces a significant loss of exclusivity wall, but the biopharma has a new drug pipeline and cost-cutting plans to cover most of the sales hits. PFE guided 2026 revenues to $61.5B, with COV
KFC debuts Open House restaurant in Texas to test new customer experiences
KFC's new Open House restaurant concept opens this Saturday in McKinney, Texas. The new store will offer expanded menu offerings, including breakfast, which is a new venture for the fast-food chain.
PTY: The Rare Discount Finally Makes This 13% Yield A Buy
PIMCO Corporate & Income Opportunity Fund is rated Buy at $10.86, trading near NAV after years of premium pricing. PTY offers a 13.1% distribution yield, but recent NAV total return (7.94%) lags the p
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages FuelCell Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FCEL
New York, New York--(Newsfile Corp. - September 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities FuelCell Ener
Embracer Group AB (publ) (EBCRY) Shareholder/Analyst Call Transcript
Embracer Group AB (publ) (EBCRY) Shareholder/Analyst Call Transcript
ACADIA Pharmaceuticals Inc. (ACAD) Discusses Top-Line Phase II Results From RADIANT Study of Remlifanserin in Alzheimer's Disease Psychosis Transcript
ACADIA Pharmaceuticals Inc. (ACAD) Discusses Top-Line Phase II Results From RADIANT Study of Remlifanserin in Alzheimer's Disease Psychosis Transcript
DPG: My Top Infrastructure Pick
Duff & Phelps Utility and Infrastructure Fund is my top infrastructure CEF pick, trading at a deep discount to peers and delivering performance. DPG offers a 7% yield with a stable, recently increase
AC Immune: Buy Continued ACI-7104 Progress, PD, And Pipeline Expansions
AC Immune maintains a "Buy" rating, driven by positive 100-week safety and immunogenicity data for ACI-7104 in early-stage Parkinson's disease. Progress in the pipeline includes Takeda-partnered ACI-2